reason report
reason strong quarter reaffirm guidanc
top line led strong volum acut
bh segment although price unexpectedli weak acut
due servic mix believ transitori natur ebitda
greater expect swb expens pressur acut margin
manag optimist progress regard labor issu
encourag behavior ss revenu perform quarter
grow reinforc belief elus ss revenu
growth goal attain next month cash flow
doj settlement seem close would allow compani
refocu take greater advantag strong balanc sheet
lever increas capital-expenditure acquisit rate
outperform price target
strong revenu perform off-set slight ebitda miss ss
revenu growth acut bh respect
strong view driven larg volum growth acut ebitda
margin pressur bottom line caus ebitda ep slightli
miss street detail preview link believ
risk reward setup improv significantli recent week view
recent pullback strong buy opportun exhibit
guidanc maintain remain street
guidanc left unchang remain line ebitda
guidanc midpoint ep midpoint exhibit
weak acut price like transitori price weak
quarter driven shift higher margin surgic patient
lower margin medic patient howev manag state
headwind abat quarter trend continu
improv earli stage believ direct
read-through due flexibl associ robust
driven volum growth strong view even despit
persist headwind lo view ss bh growth attain
next month exhibit
labor issu much less factor revenu growth call
manag note labor shortag peak
much progress year sinc make much less drag
revenu admiss growth exhibit
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
year price history/av daili volume mil
compani inform svb leerink llc research
revenu mm bad debt ep ex one-tim item
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
recent ipp rule larg bake manag guidanc
although still strong posit space manag note
net-net impact contempl ipp propos would
neutral guidanc exhibit
strong balanc sheet leverag offer flexibl
 pipelin leverag remain view floor debt
ebitda compani remain activ purchas stock
mm repo exhibit
regulatori settlement negoti remain on-going
manag optimist settlement reach
settlement reserv flat sequenti manag explain
advanc past financi implic
spent mm capit expenditur track
full year target cfo period year
ago although still robust mm net incom exhibit
ebitda estim move modestli lower
ebitda estim move
 respect exhibit
estim remain larg unchang reason strong quarter
reaffirm guidanc top line led strong volum acut
bh segment although price unexpectedli weak acut due servic mix
believ transitori natur ebitda margin greater expect swb expens
pressur acut margin manag optimist progress regard labor
encourag behavior ss revenu perform quarter grow
reinforc belief elus ss revenu growth goal attain next
month cash flow doj settlement seem close would allow
compani refocu take greater advantag strong balanc sheet lever
increas capital-expenditure acquisit
ss revenu growth acut bh respect strong
view driven larg volum growth acut ebitda margin pressur bottom line
caus ebitda ep slightli miss street detail preview link
believ risk reward setup improv significantli recent week view recent
pullback strong buy opportun
net revenu estim ebitda ep slightli miss
acut volum growth strong although price pressur
guidanc left unchang remain line ebitda midpoint
 ep midpoint
consensu remain midpoint guidanc
note guidanc updat releas assum implictli reiter graph
leerinkconsensusqoqyoyacut bpsadmiss bpsadj admiss bpsss patient day bpsrev/adj admin bpsbehavior bpsadmiss bpsadj admiss bpspatient day bpsrev/adj admin bpsexpensessalaries/net bpssupplies/net bpsother expenses/net bpsreport leerink estim consensusreport compani guidanc compani guidanc leerink estimatesconsensusnet revenu adjust ep adjust ebitda net capital-expenditure servic inc
weak acut price like transitori price weak quarter driven shift
higher margin surgic patient lower margin medic patient howev manag
state headwind abat quarter trend continu improv
earli stage
improv trend point transient price pressur acut
servic mix pressur acut price trend improvingth main driver shortfal think suggest acut side price revenu per adjust admiss weak saw quarter measur shift higher margin higher revenu surgic patient lower margin lower revenu medic patient realli sort typic pattern particularli earli year steve filtonevp cfo inc see pattern abat quarter went word surgic volum extrem weak januari got better februari got better march look like continu get better earli stage second quarter steve filtonevp cfo inc servic inc
behavior shine ss basi bh revenu increas driven volum
growth strong view even despit persist headwind lo view ss
bh growth attain next month
estim ss behavior revenu growth
labor issu much less factor revenu growth call manag note
labor shortag peak much progress year sinc
make much less drag revenu admiss growth
recent ipp rule larg bake manag guidanc although still strong
posit space manag note net-net impact contempl ipp
propos would neutral guidanc
remind releas propos inpati prospect payment system ipp rate
final would bp better averag past four
year make posit catalyst acut coverag
releas propos ipp rate increas ahead recent year
note increas oper payment rate includ benefit propos chang
uncompens care tech add-on payment low-volum hospit payment capit payment
add addit
labor issu steadili improvingy look talk pressur labor shortag realli caus us impact us back late earli think problem realli kind reach height sinc think made great deal progress certainli still remain pretti tight labor environ rest countri still pocket either shortag psychiatrist multipl psychiatrist nurs even case non-clin nonprofession clinician think made signific amount progress amount occurr sort shortag much infrequ today number year ago much less barrier revenu growth admiss growth steve filtonevp cfo inc hospit ipp rate propos final final final final rulemarket basket rate product adjust code midnight centuri cure act increas oper payment servic inc
strong balanc sheet leverag offer flexibl pipelin leverag
remain view floor debt ebitda compani remain activ
purchas stock mm repo cfo period
year ago although still robust mm net incom
debt capit ratio
regulatori settlement negoti remain on-going manag optimist
settlement reach settlement reserv flat sequenti manag
explain advanc past financi implic logist detail
spent mm capit expenditur track full year target cfo
period year ago although still robust mm net incom
capit deploy key distinguish have have-not
leader capital-expenditure expect increas averag tax reform drive increas capit
spend
doj settlement talk progressingwhat talk year-end call coupl month ago idea felt like near agreement monetari settlement govern sever non-monetari issu negoti discuss think last coupl month focu interact govern sort shift non-monetari item thing like term releas period releas conclus relat investig crimin otherwis think read continu negoti rather vigor govern think side commit bring matter conclus alway hope go faster dedic resourc make sure happen steve filtonevp cfo inc servic inc
even lap tax reform fuel increas capital-expenditure still msd
guidanc mm yoy growthmainten expans compar full-year capital-expenditure prior year capital-expenditure lower due limit replac hospit spend target capital-expenditure focus higher-return core hospit expect capit expenditur increas histor averag approxim tim mention invest capit number promis growth opportun inpati outpati reform drove increas cap expans plan increas ad capac improv facil enhanc technolog includ capit spend guid million million look continu find high-qual acquisit could littl bit higher hospit front health system pipelin continu robust add mani health system partner bode well futur capit equip renov new project exist hospit expand er capac technolog construct new servic inc
 remain option though specif focu
ebitda estim move modestli lower ebitda
estim move respect
specif focusin term deal opportun think alway difficult comment level specif obvious made point certainli concur conserv capit structur leav us lot flexibl certainli feel like posit respond opportun aris opportun present us time evalu go comment specif steve filtonevp cfo inc servic inc
ebitda estim move slightli lower
consensussvb leerinkconsensussvb leerinkconsensussvb leerinkconsensussvb leerinkconsensussvb leerinknet expense/net opex/net ebitda less inpati adj net adj patient bh inpati adj net adj patient compani guidanc compani guidanc leerink estimatesconsensusnet enu adjust ep adjust ebitda net capital-expenditure servic inc
current trade ev/ebitda consensu
incom expensessalari oper total oper adjust ebitda less ebitda depreci ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut averag share million dilut yoy dilut yoy non-recur item metricsrevenu growth less nci expense/net opex/net servic inc
caresam hospitalsinpati chang patient chang chang length chang caresam hospitalsinpati chang patient chang chang length chang servic inc
price target base pro forma ebitda leverag post
transact debt repay
downsid risk valuat includ possibl delay medicaid expans current
non-expans state delay time sale hospit asset initi improv
physician product expens reduct exposur larg earn swing result
high leverag variou on-going legal proceed may result cash outflow
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda averag ebitda view
downsid risk valuat includ govern reimburs chang part drug
inpati outpati payment updat possibl legisl judici chang coverag
expans obamacar across medicaid expans exchang contract risk privat
manag plan consolid acceler shift value-bas care singl payer
pt contempl averag ev/ebitda compar histor
takeout multipl ebitda less nci rang
downsid risk valuat includ volum pressur competit econom
headwind medicaid payment may face cut state sponsor face budget pressur
potenti cut medicar physician fee schedul wage inflat could pressur margin
downsid risk leverag
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ possibl delay medicaid expans current
non-expans state acut care segment highli concentr la vega texa
cut govern commerci payer reimburs declin receiv collect
rate pay mix pressur behavior segment
